(Q45496884)

14 December 2017

title

Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule (English)

1 reference

14 December 2017

7

1 reference

14 December 2017

Kenji Nakano

1

1 reference

14 December 2017

Ryutaro Asano

2

1 reference

14 December 2017

Kouhei Tsumoto

3

1 reference

14 December 2017

Heechung Kwon

4

1 reference

14 December 2017

William F Goins

5

1 reference

14 December 2017

Izumi Kumagai

6

1 reference

14 December 2017

Joseph C Glorioso

8

1 reference

14 December 2017

publication date

1 April 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

11

1 reference

14 December 2017

issue

4

1 reference

14 December 2017

page(s)

617-626

1 reference

Mechanisms of viral membrane fusion and its inhibition

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Herpes simplex virus: receptors and ligands for cell entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Herpesvirus entry: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Nectin and afadin: novel organizers of intercellular junctions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Stable attachment for herpes simplex virus penetration into human cells requires glycoprotein D in the virion and cell receptors that are missing for entry-defective porcine cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

HSV-1 virions engineered for specific binding to cell surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Enhancement of SIV infection with soluble receptor molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Soluble receptor-induced retroviral infection of receptor-deficient cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Targeted gene delivery by tropism-modified adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Ligand-directed targeting of genes to the site of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Cytolytic viruses as potential anti-cancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Construction of a diabody (small recombinant bispecific antibody) using a refolding system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Amino acid substitutions in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus types 1 and 2 but not for Pseudorabies virus or bovine herpesvirus 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Recombinant measles viruses efficiently entering cells through targeted receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Cellular and viral requirements for rapid endocytic entry of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Rapid method for construction of recombinant HSV gene transfer vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

7 January 2021

The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

7 January 2021

Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

7 January 2021

Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

7 January 2021

Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.012

7 January 2021

10.1016/J.YMTHE.2004.12.012

Identifiers

DOI

1 reference

14 December 2017

1 reference